Your browser doesn't support javascript.
loading
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.
Kimple, Adam J; Senior, Brent A; Naureckas, Edward T; Gudis, David A; Meyer, Ted; Hempstead, Sarah E; Resnick, Helaine E; Albon, Dana; Barfield, Wayne; Benoit, Margo McKenna; Beswick, Daniel M; Callard, Eliza; Cofer, Shelagh; Downer, Veronica; Elson, E Claire; Garinis, Angela; Halderman, Ashleigh; Hamburger, Lisa; Helmick, Meagan; McCown, Michael; McKinzie, Cameron J; Phan, Hanna; Rodriguez, Kenneth; Rubenstein, Ronald C; Severin, Ashley; Shah, Gopi; Shenoy, Ambika; Sprouse, Brittney; Virgin, Frank; Woodworth, Bradford A; Lee, Stella E.
Afiliação
  • Kimple AJ; Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina, Chapel Hill, North Carolina, USA.
  • Senior BA; Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina, Chapel Hill, North Carolina, USA.
  • Naureckas ET; Department of Pulmonary Medicine, Critical Care Medicine, University of Chicago Medicine, Chicago, Illinois, USA.
  • Gudis DA; Department of Otolaryngology - Head and Neck Surgery, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Meyer T; Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina, Chapel Hill, North Carolina, USA.
  • Hempstead SE; Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, South Carolina, USA.
  • Resnick HE; Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
  • Albon D; Resnick, Chodorow & Associates, USA.
  • Barfield W; Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA.
  • Benoit MM; Pediatric and Adult CF Center, Medical University of South Carolina, South Carolina, USA.
  • Beswick DM; Department of Otolaryngology-Head and Neck Surgery, University of Rochester Medical Center, Rochester, New York, USA.
  • Callard E; Department of Head and Neck Surgery, University of California, Los Angeles, California, USA.
  • Cofer S; Community Advisor to the Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
  • Downer V; Mayo Clinic-Otolaryngology (ENT)/Head and Neck Surgery, Rochester, Minnesota, USA.
  • Elson EC; Michigan Medicine, University of Michigan, Michigan, USA.
  • Garinis A; Department of Pharmacy, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Halderman A; Oregon Hearing Research Center, Oregon Health & Science University, Portland, Oregon, USA.
  • Hamburger L; Department of Otolaryngology/Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Helmick M; Community Advisor to the Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
  • McCown M; Community Advisor to the Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
  • McKinzie CJ; Department of Pediatrics, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Phan H; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
  • Rodriguez K; College of Pharmacy, Department of Clinical Pharmacy, The University of Michigan, C.S. Mott Children's Hospital, Michigan Medicine, Michigan, USA.
  • Rubenstein RC; Department of Otolaryngology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Severin A; Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Shah G; Department of Social Work, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Shenoy A; Department of Otolaryngology/Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Sprouse B; Department of Pediatrics, Division of Pediatric Pulmonology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA.
  • Virgin F; Department of Pediatrics, Division of Pediatric Pulmonology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA.
  • Woodworth BA; University of Chicago Medicine, Chicago, Illinois, USA.
  • Lee SE; Department of Otolaryngology - Head and Neck Surgery, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.
Int Forum Allergy Rhinol ; 12(9): 1089-1103, 2022 09.
Article em En | MEDLINE | ID: mdl-35089650
BACKGROUND: Cystic fibrosis (CF) is a multisystem disease that often requires otolaryngology care. Individuals with CF commonly have chronic rhinosinusitis but also present with hearing loss and dysphonia. Given these manifestations of CF, otolaryngologists are frequently involved in the care of patients with CF; however, there is limited consensus on optimal management of sinonasal, otologic, and laryngologic symptoms. METHODS: The Cystic Fibrosis Foundation convened a multidisciplinary team of otolaryngologists, pulmonologists, audiologists, pharmacists, a social worker, a nurse coordinator, a respiratory therapist, two adults with CF, and a caregiver of a child with CF to develop consensus recommendations. Workgroups developed draft recommendation statements based on a systematic literature review, and a ≥80% consensus was required for acceptance of each recommendation statement. RESULTS: The committee voted on 25 statements. Eleven statements were adopted recommending a treatment or intervention, while five statements were formulated recommending against a specific treatment or intervention. The committee recommended eight statements as an option for select patients in certain circumstances, and one statement did not reach consensus. CONCLUSION: These multidisciplinary consensus recommendations will help providers navigate decisions related to otolaryngology consultation, medical and surgical management of CF-CRS, hearing, and voice in individuals with CF. A collaborative and multidisciplinary approach is advocated to best care for our patients with CF. Future clinical research is needed utilizing standardized, validated outcomes with comprehensive reporting of patient outcome, effects of modulator therapies, and genetic characteristics to help continue to advance care, decrease morbidity, and improve the quality of life for individuals with CF.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Otolaringologia / Sinusite / Fibrose Cística Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: Int Forum Allergy Rhinol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Otolaringologia / Sinusite / Fibrose Cística Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: Int Forum Allergy Rhinol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos